Clinical Trials Browser

Phase 2 × Thyrotropin Alfa × 30 days × Clear all

NCT03841617 2026-06-05

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

Phase 2 Recruiting

Neoplasm Metastasis, Thyroid Neoplasms